Comparison

OR-1855

Item no. CS-0031338-100mg
Manufacturer ChemScene
Amount 100mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 101328-85-2
Similar products 101328-85-2
Available
CAS
101328-85-2
Purity
>98%
MWt
203.24
Formula
C11H13N3O
Solubility
10 mM in DMSO
Clinical Information
No Development Reported
Pathway
Metabolic Enzyme/Protease; Autophagy; Membrane Transporter/Ion Channel
Target
Phosphodiesterase (PDE); Autophagy; Potassium Channel
Biological Activity
OR-1855, an active metabolite of Levosimendan, has effect on human myometrial contractility. Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure[1][2].
Research Area
Cardiovascular Disease

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close